Literature DB >> 30353369

Long noncoding RNA UCA1 promotes the proliferation of hypoxic human pulmonary artery smooth muscle cells.

Tian-Tian Zhu1, Rui-Li Sun2, Ya-Ling Yin3, Jin-Ping Quan1, Ping Song1, Jian Xu1, Ming-Xiang Zhang1, Peng Li4.   

Abstract

Our study explored the effects of lncRNA UCA1 on the proliferation and apoptosis in hypoxic human pulmonary artery smooth muscle cells (HPASMCs) and highlighted the endogenous relationship between UCA1, ING5, and hnRNP I in cell proliferation. Hypoxia-induced HPASMCs were used to simulate pulmonary arterial hypertension in vitro. Microarray assay was adopted to screen the dysregulated expressed lncRNAs in HPASMCs to find out the target gene of our study. And RT-qPCR was performed to detect the expression of lncRNA UCA1 under hypoxia and normoxia. After transfection, the relationship between UCA1 and cell proliferation in HPASMCs under hypoxia were determined by cell proliferation assay and relative expression of PCNA. Next, ELISA assays were conducted to measure the protein levels of PCNA and ING5. What's more, flow cytometry was employed to measure the apoptosis rate in differentially UCA1-expressed HPASMCs. RIP assays were conducted to further clarify the endogenous relationship between UCA1 and ING5 in hypoxic HPASMCs. Finally, the effects of ING5 to HPASMCs were detected after transfection of ING5 and UCA1 to figure out the role of ING5 in HPASMCs. Hypoxia was revealed to induce proliferation and inhibited apoptosis in HPASMCs. Besides, UCA1 was confirmed to be highly expressed under hypoxia compared with normoxia. UCA1 boosted cell proliferation under hypoxia in HPASMCs. However, the apoptosis was suppressed in the hypoxic HPASMCs transfected with pcDNA3.1-UCA1. Further, mechanism studies found that UCA1 competed with ING5 for hnRNP I, so that upregulating UCA1 inhibited the protein levels of ING5. And finally we found that ING5 restrained cell viability, but promoted cell apoptosis in hypoxic HPASMCs, which was reversed by UCA1 over-expression. In summary, our findings manifested that UCA1 promoted proliferation and restrained apoptosis by competing with ING5 for hnRNP I in HPASMCs induced by hypoxia, indicating their potential roles for the cure of hypoxic pulmonary hypertension.

Entities:  

Keywords:  HPASMCs; Hypoxia; ING5; Pulmonary hypertension; UCA1

Mesh:

Substances:

Year:  2018        PMID: 30353369     DOI: 10.1007/s00424-018-2219-8

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  35 in total

Review 1.  Treatment of pulmonary arterial hypertension.

Authors:  Marc Humbert; Olivier Sitbon; Gérald Simonneau
Journal:  N Engl J Med       Date:  2004-09-30       Impact factor: 91.245

Review 2.  Long non-coding RNAs: insights into functions.

Authors:  Tim R Mercer; Marcel E Dinger; John S Mattick
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

3.  Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.

Authors:  Matthias Brock; Claudio Schuoler; Caroline Leuenberger; Carlo Bühlmann; Thomas J Haider; Johannes Vogel; Silvia Ulrich; Max Gassmann; Malcolm Kohler; Lars C Huber
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-05

Review 4.  After a decade of study-ING, a PHD for a versatile family of proteins.

Authors:  Mohamed A Soliman; Karl Riabowol
Journal:  Trends Biochem Sci       Date:  2007-10-18       Impact factor: 13.807

5.  Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion.

Authors:  Mei Xue; Xu Li; Zhengkun Li; Wei Chen
Journal:  Tumour Biol       Date:  2014-04-16

6.  Down-regulation of lncRNA MEG3 promotes hypoxia-induced human pulmonary artery smooth muscle cell proliferation and migration via repressing PTEN by sponging miR-21.

Authors:  Boqian Zhu; Yaoyao Gong; Gaoliang Yan; Dong Wang; Yong Qiao; Qingjie Wang; Bo Liu; Jiantong Hou; Ruifeng Li; Chengchun Tang
Journal:  Biochem Biophys Res Commun       Date:  2017-12-02       Impact factor: 3.575

Review 7.  Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease.

Authors:  Masaharu Kataoka; Da-Zhi Wang
Journal:  Cells       Date:  2014-08-22       Impact factor: 6.600

8.  Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China.

Authors:  Yanlong Yang; Kai Chen; Yongchun Zhou; Zaoxiu Hu; Shuai Chen; Yunchao Huang
Journal:  Onco Targets Ther       Date:  2018-01-30       Impact factor: 4.147

Review 9.  Mechanisms of disease: pulmonary arterial hypertension.

Authors:  Ralph T Schermuly; Hossein A Ghofrani; Martin R Wilkins; Friedrich Grimminger
Journal:  Nat Rev Cardiol       Date:  2011-06-21       Impact factor: 32.419

Review 10.  Noncoding RNA in age-related cardiovascular diseases.

Authors:  Simona Greco; Myriam Gorospe; Fabio Martelli
Journal:  J Mol Cell Cardiol       Date:  2015-01-29       Impact factor: 5.000

View more
  14 in total

Review 1.  'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension.

Authors:  Emilia M Swietlik; Matina Prapa; Jennifer M Martin; Divya Pandya; Kathryn Auckland; Nicholas W Morrell; Stefan Gräf
Journal:  Genes (Basel)       Date:  2020-11-26       Impact factor: 4.096

Review 2.  Noncoding RNAs in Hypertension.

Authors:  Amela Jusic; Yvan Devaux
Journal:  Hypertension       Date:  2019-07-29       Impact factor: 10.190

3.  Upregulation of miR-376c-3p alleviates oxygen-glucose deprivation-induced cell injury by targeting ING5.

Authors:  Heng Zhang; Jie Zhou; Mingxia Zhang; Yanjie Yi; Bing He
Journal:  Cell Mol Biol Lett       Date:  2019-12-04       Impact factor: 5.787

Review 4.  Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension.

Authors:  William Gerthoffer
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

5.  Transfer of lncRNA UCA1 by hUCMSCs-derived exosomes protects against hypoxia/reoxygenation injury through impairing miR-143-targeted degradation of Bcl-2.

Authors:  Liwei Diao; Qinghua Zhang
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

6.  Urothelial Cancer Associated 1 (UCA1) and miR-193 Are Two Non-coding RNAs Involved in Trophoblast Fusion and Placental Diseases.

Authors:  Clara Apicella; Camino S M Ruano; Sébastien Jacques; Géraldine Gascoin; Céline Méhats; Daniel Vaiman; Francisco Miralles
Journal:  Front Cell Dev Biol       Date:  2021-05-13

7.  Dysregulated lncRNA TUG1 in different pulmonary artery cells under hypoxia.

Authors:  Zhenchun Lv; Rong Jiang; Xiaoyi Hu; Qinhua Zhao; Yuanyuan Sun; Lan Wang; Jinling Li; Yuqing Miao; Wenhui Wu; Ping Yuan
Journal:  Ann Transl Med       Date:  2021-05

Review 8.  RNA-Binding Proteins in Pulmonary Hypertension.

Authors:  Hui Zhang; R Dale Brown; Kurt R Stenmark; Cheng-Jun Hu
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

9.  LncRNA CASC2 inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation and migration by regulating the miR-222/ING5 axis.

Authors:  Yan Han; Yuhao Liu; Chaokuan Yang; Chuanyu Gao; Xiaoyan Guo; Jiangtao Cheng
Journal:  Cell Mol Biol Lett       Date:  2020-03-17       Impact factor: 5.787

10.  Emodin inhibits viability, proliferation and promotes apoptosis of hypoxic human pulmonary artery smooth muscle cells via targeting miR-244-5p/DEGS1 axis.

Authors:  Li Yi; JunFang Liu; Ming Deng; Huihua Zuo; Mingyan Li
Journal:  BMC Pulm Med       Date:  2021-07-31       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.